Lsrii flow cytometer, high throughput sampler, & facs flow supply system corrective/remedial repair and preventive maintenance service

Ended Awarded Last action

Contract number
75F40121F80061
Awardee
Awarding agency
Obligated
$33,517

Award facts

Contract value 100% obligated
$33,516.73 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
No set-aside
Competition
Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
San Jose, CA 95131, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 · The purpose of this modification is to DE-obligate funds and close out the contract. -$2,640
Other Administrative Action P00002 $0
Exercise an Option P00001 $15,496
Original award $20,661

About this award

This delivery order, issued by the Food and Drug Administration on February 17, 2021, awards Becton, Dickinson and Company (BD Biosciences division) $33,516.73 for corrective/remedial repair and preventive maintenance services on an LSRII flow cytometer, high-throughput sampler, and FACS flow supply system located in San Jose, California. The contract was executed under the Multiple Award Schedule vehicle and utilized firm fixed price terms without a small business set-aside. This modification, completed on February 21, 2023, de-obligated remaining funds and closed out the delivery order, concluding FDA's procurement of specialized instrumentation maintenance support from this established supplier of biomedical research equipment.

BD Biosciences represents a critical federal supplier of flow cytometry systems and associated technical services, with extensive experience maintaining complex laboratory instrumentation across multiple government agencies including the Department of Veterans Affairs, National Institutes of Health, Defense Health Agency, and Centers for Disease Control and Prevention. The company's federal service portfolio encompasses preventive maintenance, emergency repairs, on-site technical support, and comprehensive training for flow cytometry platforms essential to biomedical research and clinical diagnostics operations. FDA's engagement with BD reflects the agency's reliance on sophisticated analytical instrumentation and qualified service providers to support its regulatory and scientific missions in laboratory analysis and research support.

Quick answers

Who was awarded contract 75F40121F80061?

75F40121F80061 was awarded to Becton, Dickinson And Company by Food and Drug Administration (Department of Health and Human Services) on February 17, 2021.

How much is contract 75F40121F80061 worth?

The government has obligated $33,517 on 75F40121F80061.

Is contract 75F40121F80061 an order under another contract?

Yes. 75F40121F80061 is a delivery order under GS07F195DA, a federal supply schedule, on Multiple Award Schedule (MAS).

Was contract 75F40121F80061 competed?

The extent of competition for 75F40121F80061 was full and open competition. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award